US HB3805 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on July 17 2019 - 25% progression, died in committee
Action: 2019-07-18 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 17 2019 - 25% progression, died in committee
Action: 2019-07-18 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires private health insurance plans to set any coinsurance rate for a covered prescription drug based on the net price of the drug (the price after accounting for rebates and discounts provided by the drug manufacturer) and not the list price (the initial wholesale price set by the drug manufacturer). This requirement applies when a plan holder has an unmet deductible or other coinsurance obligation for prescription drug benefits under the plan.The bill does not prohibit a plan from requiring a copayment provided that such copayment is not based on the cost of the drug.
Title
Prescription Drug Rebate Reform Act of 2019
Sponsors
Rep. Mike Gallagher [R-WI] |
History
Date | Chamber | Action |
---|---|---|
2019-07-18 | House | Referred to the Subcommittee on Health. |
2019-07-17 | House | Referred to the House Committee on Energy and Commerce. |
2019-07-17 | House | Introduced in House |
Same As/Similar To
SB1384 (Same As) 2019-05-09 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Health
Health care costs and insurance
Health care coverage and access
Inflation and prices
Prescription drugs
Health care costs and insurance
Health care coverage and access
Inflation and prices
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/3805/all-info |
Text | https://www.congress.gov/116/bills/hr3805/BILLS-116hr3805ih.pdf |